Latest Novo Nordisk Stories

2013-09-24 23:27:47

Global Hemophilia Market Report: 2013 Edition research studies the hemophilia market on a global scale and its various segments. Dallas, Texas (PRWEB) September 24, 2013 The key trends observed within the global hemophilia market include inclination towards prophylaxis, long-acting factor VIII and IX development and growing penetration of rFVIII products in emerging markets which is a opportunity for manufacturers. On the development front, there has been an increase in the launch of new...

2013-09-06 23:21:39

d’Oliveira & Associates has posted a new infographic about the type-2 diabetes drug Victoza. The law firm now works with experienced lawyers, who are filing cancer lawsuits. (PRWEB) September 06, 2013 Victoza (liraglutide) is a once-daily injection used to control blood sugar levels in type-2 diabetes patients. This medicine increases insulin while making the stomach feel full. The FDA approved this drug in January 2010 and it earned more than $2.3 billion in sales its first year...

2013-08-29 23:02:45

The firm is currently evaluating Byetta, Victoza and Januvia lawsuits for those who have suffered from the drugs’ alleged potentially serious side effects, such as pancreatic cancer and thyroid cancer. (PRWEB) August 29, 2013 Byetta, Januvia and Victoza lawsuits were consolidated on Aug. 28 in federal district court in California, according to court documents. The Rottenstein Law Group LLP, a diabetes drug law firm, explains what this means for those looking to file lawsuits over the...

Word of the Day
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).